Private https://www.bioworld.com/rss en-us Taiwan’s cancer focused Anbogen raises $12.5M in series A round http://www.bioworld.com/articles/705403 Tue, 06 Feb 2024 12:00:00 -0500 https://www.bioworld.com/articles/705403-taiwans-cancer-focused-anbogen-raises-125m-in-series-a-round Anbogen Taiwan’s cancer focused Anbogen raises $12.5M in series A round http://www.bioworld.com/articles/705222 Fri, 02 Feb 2024 12:00:00 -0500 https://www.bioworld.com/articles/705222-taiwans-cancer-focused-anbogen-raises-125m-in-series-a-round Anbogen TYRA-300 designated rare pediatric disease drug; Tyra collects $200M http://www.bioworld.com/articles/705218 Fri, 02 Feb 2024 12:00:00 -0500 https://www.bioworld.com/articles/705218-tyra-300-designated-rare-pediatric-disease-drug-tyra-collects-200m Rare disease illustration Chinese CAR T-maker Gracell raises $150M in private financing http://www.bioworld.com/articles/699781 Tue, 08 Aug 2023 12:00:00 -0400 https://www.bioworld.com/articles/699781-chinese-car-t-maker-gracell-raises-150m-in-private-financing CAR T cells attacking cancer cell A born listener: CNS startup Violet hones in on cellular cross-talk http://www.bioworld.com/articles/699447 Fri, 28 Jul 2023 09:00:00 -0400 https://www.bioworld.com/articles/699447-a-born-listener-cns-startup-violet-hones-in-on-cellular-cross-talk Startup key, rocket icon A born listener: CNS startup Violet hones in on cellular cross-talk http://www.bioworld.com/articles/699408 Thu, 27 Jul 2023 09:00:00 -0400 https://www.bioworld.com/articles/699408-a-born-listener-cns-startup-violet-hones-in-on-cellular-cross-talk A born listener: CNS startup Violet hones in on cellular cross-talk http://www.bioworld.com/articles/699179 Tue, 25 Jul 2023 12:00:00 -0400 https://www.bioworld.com/articles/699179-a-born-listener-cns-startup-violet-hones-in-on-cellular-cross-talk Coins and seedling Cellusion raises ¥2.83B series C round to progress iPS cell-derived corneal substitute http://www.bioworld.com/articles/698012 Tue, 13 Jun 2023 12:00:00 -0400 https://www.bioworld.com/articles/698012-cellusion-raises-283b-series-c-round-to-progress-ips-cell-derived-corneal-substitute Yen-Yuan symbols Cellusion raises ¥2.83B series C round to progress iPS cell-derived corneal substitute http://www.bioworld.com/articles/697703 Wed, 07 Jun 2023 12:00:00 -0400 https://www.bioworld.com/articles/697703-cellusion-raises-283b-series-c-round-to-progress-ips-cell-derived-corneal-substitute Yen-Yuan symbols Mediwhale raises $9M series A round for AI-powered retina scans to detect chronic disease http://www.bioworld.com/articles/696606 Tue, 02 May 2023 13:00:00 -0400 https://www.bioworld.com/articles/696606-mediwhale-raises-9m-series-a-round-for-ai-powered-retina-scans-to-detect-chronic-disease Mediwhale scan Mediwhale retina scan Surgerii completes series C3 financing to develop robot for single-port laparoscopy http://www.bioworld.com/articles/696218 Wed, 19 Apr 2023 13:00:00 -0400 https://www.bioworld.com/articles/696218-surgerii-completes-series-c3-financing-to-develop-robot-for-single-port-laparoscopy Yen-Yuan symbols Flood of funding lifts Noah’s ark with $150M series B http://www.bioworld.com/articles/696215 Wed, 19 Apr 2023 13:00:00 -0400 https://www.bioworld.com/articles/696215-flood-of-funding-lifts-noahs-ark-with-150m-series-b Noah Medical Noah Medical's Galaxy system. Credit: Noah Medical Kiro raises €13.8M for AI platform to simplify lab results BioWorld, there is a huge “opportunity” for the AI platform following changes to regulations which require laboratories to communicate test results directly to patients.]]> http://www.bioworld.com/articles/696149 Tue, 18 Apr 2023 13:00:00 -0400 https://www.bioworld.com/articles/696149-kiro-raises-138-million-for-ai-platform-to-simplify-lab-results Neuromod prepares to launch tinnitus treatment in the US after €30M raise BioWorld. “To get this financing closed is very exciting as we go into the U.S. market which is the biggest hearing market in the world,” he added.]]> http://www.bioworld.com/articles/696110 Mon, 17 Apr 2023 13:00:00 -0400 https://www.bioworld.com/articles/696110-neuromod-prepares-to-launch-tinnitus-treatment-in-the-us-after-30m-raise Neuromod patient using Lenire A woman using Neuromod’s Lenire device Epic Sciences lands $24M for blood-based test for metastatic breast cancer http://www.bioworld.com/articles/696078 Fri, 14 Apr 2023 13:00:00 -0400 https://www.bioworld.com/articles/696078-epic-sciences-lands-24m-for-blood-based-test-for-metastatic-breast-cancer Andera leads $48.5M financing for Bioventrix http://www.bioworld.com/articles/696077 Fri, 14 Apr 2023 13:00:00 -0400 https://www.bioworld.com/articles/696077-andera-leads-485m-financing-for-bioventrix BioVentrix - TC System Bioventrix Revivent TC system Function Oncology quietly raised $28M for gene function approach to precision oncology http://www.bioworld.com/articles/695992 Wed, 12 Apr 2023 13:00:00 -0400 https://www.bioworld.com/articles/695992-function-oncology-quietly-raised-28m-for-gene-function-approach-to-precision-oncology Bain pumps $215M into Heartflow as series F lead investor http://www.bioworld.com/articles/695862 Thu, 06 Apr 2023 13:00:00 -0400 https://www.bioworld.com/articles/695862-bain-pumps-215m-into-heartflow-as-series-f-lead-investor Oxos Medical lands $23M for versatile smart X-ray platform http://www.bioworld.com/articles/695817 Wed, 05 Apr 2023 13:00:00 -0400 https://www.bioworld.com/articles/695817-oxos-medical-lands-23m-for-versatile-smart-x-ray-platform Oxos Medical Oxos Medical's Micro C Mercy Bioanalytics closes $41M financing for Halo early cancer detection platform http://www.bioworld.com/articles/695769 Tue, 04 Apr 2023 13:00:00 -0400 https://www.bioworld.com/articles/695769-mercy-bioanalytics-closes-41m-financing-for-halo-early-cancer-detection-platform Shoulder Innovation receives broad shouldered investor support for integrated Inset system http://www.bioworld.com/articles/695630 Thu, 30 Mar 2023 13:00:00 -0400 https://www.bioworld.com/articles/695630-shoulder-innovation-receives-broad-shouldered-investor-support-for-integrated-inset-system Vas Medical nets $15M, obtains Chinese approval for vascular interventional surgery robot http://www.bioworld.com/articles/695523 Mon, 27 Mar 2023 13:00:00 -0400 https://www.bioworld.com/articles/695523-vas-medical-nets-15m-obtains-chinese-approval-for-vascular-interventional-surgery-robot Yongrenxin Medical nets $100M in financing for heart failure platform http://www.bioworld.com/articles/695405 Thu, 23 Mar 2023 13:00:00 -0400 https://www.bioworld.com/articles/695405-yongrenxin-medical-nets-100m-in-financing-for-heart-failure-platform Evaheart Yongrenxin Medical Instrument Evaheart left ventricular assist device. Credit: Yongrenxin Medical Instrument Co. Ltd. Mvision raises €5.4M to accelerate cancer treatment http://www.bioworld.com/articles/695403 Thu, 23 Mar 2023 13:00:00 -0400 https://www.bioworld.com/articles/695403-mvision-raises-54m-to-accelerate-cancer-treatment Mvision software Mvision AI's artificial intelligence-powered automatic segmentation software Vitestro raises $12.7M to bring its autonomous blood drawing device to EU market BioWorld.]]> http://www.bioworld.com/articles/695373 Wed, 22 Mar 2023 13:00:00 -0400 https://www.bioworld.com/articles/695373-vitestro-raises-127m-to-bring-its-autonomous-blood-drawing-device-to-eu-market Vitestro total autonomous collection Vitestro total autonomous collection. Copyright: Vitestro BV AI drug discovery startup Protai raises $12M in seed funding http://www.bioworld.com/articles/695335 Tue, 21 Mar 2023 12:00:00 -0400 https://www.bioworld.com/articles/695335-ai-drug-discovery-startup-protai-raises-12m-in-seed-funding Kirill Pevzner and Eran Seger - Protai Protai Bio Ltd founders: Chief Technology Officer Kirill Pevzner, left, and CEO Eran Seger. Credit: David Garb AI drug discovery startup Protai raises $12M in seed funding http://www.bioworld.com/articles/695151 Fri, 17 Mar 2023 12:00:00 -0400 https://www.bioworld.com/articles/695151-ai-drug-discovery-startup-protai-raises-12m-in-seed-funding Kirill Pevzner and Eran Seger - Protai Protai Bio Ltd founders: Chief Technology Officer Kirill Pevzner, left, and CEO Eran Seger. Credit: David Garb Seamless Therapeutics closes $12.5M seed round for new gene editing platform http://www.bioworld.com/articles/695131 Thu, 16 Mar 2023 12:00:00 -0400 https://www.bioworld.com/articles/695131-seamless-therapeutics-closes-125m-seed-round-for-new-gene-editing-platform DNA illustration Skin in the game: Aldena raises $30M to move siRNA into dermatology http://www.bioworld.com/articles/695128 Thu, 16 Mar 2023 12:00:00 -0400 https://www.bioworld.com/articles/695128-skin-in-the-game-aldena-raises-30m-to-move-sirna-into-dermatology Coins and seedling Doctorly prescribed $10M to expand its cloud computing system for German medical practices http://www.bioworld.com/articles/695095 Tue, 14 Mar 2023 13:00:00 -0400 https://www.bioworld.com/articles/695095-doctorly-prescribed-10m-to-expand-its-cloud-computing-system-for-german-medical-practices Doctorly1 General picture of Doctorly. Copyright: Doctorly GmbH.